baber/WOPTO huggingface dataset:
Patent AU-735657-B2 (AU)
Title: Motor-driven toothbrush, in particular an electric toothbrush
Inventor: FISCHER FRANZ
IPC: A61C17/22
Filed: 1997-11-28
Granted: 2001-07-12
Abstract: The electric toothbrush has a rotary brush head (5), with spaced bristles attached to a bristle support (10), extending at an angle to the longitudinal axis (A) of the toothbrush, which is provided by a hollow longitudinal body with 2 sections (3,4) coupled via a flexure area. The latter allows the head to be pushed backwards when force is applied to the brushing surface, with the drive connection to the brush head maintained.
Patent AU-776457-B2 (AU)
Title: Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as NGF-antagonist molecules
Inventor: NOVAK MICHAL M
IPC: A61K39/00
Filed: 2000-05-26
Granted: 2004-09-09
Abstract: Monoclonal antibodies, synthetic and biotechnological derivatives thereof (ScFv or others) are able to recognise the NGF high affinity receptor, TrkA, and act as NGF-antagonist molecules. Pharmacological compositions for therapy, gene therapy, diagnostics of neurological pathologies are also described. Transgenic animal models to study such pathologies are also described.
Patent AU-673015-B2 (AU)
Title: Catheter for RF ablation with cooled electrode and method
Inventor: IMRAN MIR A
IPC: A61B18/00
Filed: 1993-11-30
Granted: 1996-10-24
Abstract: The present invention relates to a catheter (11) for radio frequency ablation with a cooled electrode for use in tissue having a surface comprising an elongate member (12) having proximal and distal extremities (13,14). A metal conducting electrode (16) is secured to the distal extremity (14) of the elongate member (12) and has a chamber (17) therein. A conductor (31) extends through the elongate member (12) from the proximal (13) to the distal extremity (14) for supplying radio frequency energy to the electrode (16). The elongate member (12) has a lumen (26,27) in the distal extremity (14) which is in communication with the chamber (17). A coolant is disposed in the chamber (17) and in contact with the electrode (16) by the application of radio frequency energy thereto. <IMAGE>
Patent AU-601360-B2 (AU)
Title: Monoclonal antibodies and antigen for human non-small cell lung carcinomas
Inventor: HELLSTROM INGEGERD
IPC: C12N5/10
Filed: 1985-12-13
Granted: 1990-09-13
Abstract: The present invention is concerned with novel monoclonal antibodies which define a glycolipid antigen associated with human non-small cell lung carcinomas ("NSCLC") and certain other human carcinomas. The antibodies bind to normal human cells to a much lesser degree than to tumor cells. The antibodies find use in diagnostic methods such as the detection of malignant cells associated with NSCLC and in therapeutic methods. Also disclosed in a novel glycolipid antigen. The invention also comprises a method for determining the presence of a malignant condition in lung tissue and other human tissue. The method involves examining the human tissue for the presence of a glycolipid antigen having the terminal carbohydrate sequence: GalNAc beta l->4Gal beta l->3GalNAc beta l->4Gal beta l->R.
Patent AU-526780-B2 (AU)
Title: Aligning rail ends
Inventor: BOMMART PATRICK
IPC: E01B29/46
Filed: 1980-01-22
Granted: 1983-01-27
Abstract: An improved apparatus for aligning and setting the gap between two rail ends comprises a rigid housing overlapping the two rails and providing an access area around the two rail ends. A first pair of presses and a second pair of presses are mounted in line on the frame and arranged so that the first pair of presses is situated between the second pair of presses. Each combination of a first press and a second press serves to grip one of the two rails to be joined. A pair of vertically mounted jacks are operatively secured to the second pair of presses to provide vertical movement of the second pair of presses independent of the rigid housing. Vertically adjustable support stops engage the tops of the rails and together with the vertically adjustable second presses effect vertical adjustment of the rails. The improved apparatus can be mounted singly or in pairs on a gantry and can include gap setting apparatus and weld dressing apparatus.
Patent AU-760478-B2 (AU)
Title: A process and a plant for spray drying
Inventor: HANSEN OVE EMIL
IPC: B01D46/24
Filed: 1999-09-29
Granted: 2003-05-15
Abstract: In a compact combined spray drying and after-treatment apparatus having internal gas filters and an internal fluidized bed in the drying chamber and a fluidized bed in the after-treatment zone, pipe means are used for conducting a stream of particle-loaded gas formed in the after-treatment zone to suitable locations in the drying chamber without disturbing the normal operation of the drying chamber and the fluidized bed therein.
Patent AU-733326-B2 (AU)
Title: Catheter for providing a fluid connection with the small intestine
Inventor: BENGMARK STIG
IPC: A61J15/00
Filed: 1998-02-02
Granted: 2001-05-10
Abstract: Probe for providing a fluid connection with the small intestine comprising a tube ( 10 ) to be inserted in the small intestine via the stomach, having proximal and distal open ends ( 10 A, 10 B) and inherent tendency of coiling over a predetermined length at the distal end, and a guide ( 14 ) displaceable in the tube from the proximal end for straightening said length in order that it shall be straightened during the actual insertion into the stomach. According to the invention the tube has at least in said predetermined portion a hairy, frosted, rough, ribbed or finned outside surface ( 16 ).
Patent AU-685421-B2 (AU)
Title: Carrier, particularly for several bottles
Inventor: HANSEN FINN R
IPC: B65D71/46
Filed: 1994-02-03
Granted: 1998-01-22
Abstract: A carrier (10; 10') for a series of bottles (2) having an upwardly conically converging neck (3) and an upper end (7) showing an outer thread for a screw cap (8), or a capsule fastened to an upper bottle collar. The carrier comprises initially a substantially flat sheet (1; 1') made of corrugated cardboard having five longitudinal sections, namely a central section (11; 11'), to the longitudinal edges of which connect two intermediate sections (12; 12' and 13; 13'), to which latter in their turn connect two outer sections (14; 14' and 15; 15'). The sections are separated from each other by grooves (17) and have openings (20; 20'; 21; 21', 22; 22'), which will be aligned, when the sheet is folded to a closed form of profile, and which openings are designed to be penetrated by the neck (3) and the cap (8) of the bottles (2). According to the invention, said sheet and said carrier, respectively, have in the central section (11; 11') foldable flaps (27; 27'; 27'') and in the intermediate sections (12; 12'; 13; 13') support flaps (24; 24'; 24''). The flaps are pressed against the cap (8) of the bottles (2) or against any flange (4) or an outer section (14; 14') and the neck (3) to counteract relative movements between the bottles and the carrier respectively for mutual coordination of the latter. The support flaps support and lock the flaps in the position of use.
Patent AU-708756-B2 (AU)
Title: Composition for sustained release of human growth hormone
Inventor: JOHNSON OLUFUNMI LILY
IPC: A61K9/16
Filed: 1996-06-03
Granted: 1999-08-12
Abstract: A composition, and methods of forming and using said composition, for the sustained release of biologically active, stabilized human growth hormone (hGH). The sustained release composition of this invention comprises a polymeric matrix of a biocompatible polymer and particles of biologically active, stabilized hGH, wherein said particles are dispersed within the biocompatible polymer. The method of the invention for producing a composition for the sustained release of biologically active hGH, includes dissolving a biocompatible polymer in a polymer solvent to form a polymer solution, dispersing particles of biologically active, metal cation-stabilized hGH in the polymer solution, and then solidifying the polymer to form a polymeric matrix containing a dispersion of said hGH particles. The method for using a composition of the invention is a method for providing a therapeutically effective blood level of biologically active, non-aggregated hGH in a subject for a sustained period. In this method, a subject is administered an effective dose of the sustained release composition of the present invention. The method of using the sustained release composition of the present invention comprises providing a therapeutically effective blood level of biologically active, non-aggregated human growth hormone in a subject for a sustained period by administering to the subject a dose of said sustained release composition.
Patent AU-623328-B2 (AU)
Title: Metering and grinding apparatus
Inventor: BUHLER MARCEL
IPC: B02C13/13
Filed: 1990-10-10
Granted: 1992-05-07
Abstract: Apparatus for controlled delivery and for milling comprising a controlled-delivery screw (1), a beater (2) formed by bars (3) attached to the helical perimeter of the downstream end of the screw (1), and a cylindrical screen (6) lying in the extension of the cylindrical casing (5) and surrounding the beater (2). 
<IMAGE>
Patent AU-771756-B2 (AU)
Title: Rapid transfer autotransfusion bag and methods related thereto
Inventor: LORD KEVIN M
IPC: A61M5/14
Filed: 1999-10-13
Granted: 2004-04-01
Abstract: Featured is a rapid transfer autotransfusion device and a system using such a device. Also featured are methods related to the collection and/or the re-infusion of collected blood to a patient. The autotransfusion device includes an actuator handle assembly having two arms, a top plate, a bottom plate and a flexible container secured to and between opposing surfaces of the top and bottom plates. The bottom plate includes a projection from two opposing sides thereof, that each rotatably engage a lower portion of an actuator handle arm. The actuator handle rotates about the bottom plate projections between a first position and a second position. The actuator handle further includes a follower member, having a first and second portion, and a displacing mechanism that is disposed in at least one actuator handle arm, more particularly, disposed in each actuator handle arm. The first portion of each follower member movably engages a portion of the top plate as the actuator handle moves between the first and second position. The displacing mechanism is configured to act on the second portion of the follower member at least when the actuator handle is moved to the second position so the follower member first portion is movably displaced thereby and so the opposing surface of the top plate is displaced with respect to the opposing surface of the bottom plate.
Patent AU-694111-B2 (AU)
Title: Inhibitor of stem cell proliferation and uses thereof
Inventor: KOZLOV VLADIMIR
IPC: C07H21/04
Filed: 1994-03-29
Granted: 1998-07-16
Abstract: Disclosed and claimed are methods for the isolation and use of stem cell inhibiting factors for regulating the abnormal stem cell cycle and for accelerating the post-chemotherapy peripheral blood cell recovery. Also disclosed and claimed are the inhibitors of stem cell proliferation.
Patent AU-674576-B2 (AU)
Title: Deconvolution of MLS response data
Inventor: THORNTON ARTHUR ROGER DAVID
IPC: G06F17/10
Filed: 1994-04-22
Granted: 1997-01-02
Abstract: PCT No. PCT/GB94/00862 Sec. 371 Date Oct. 20, 1995 Sec. 102(e) Date Oct. 20, 1995 PCT Filed Apr. 22, 1994 PCT Pub. No. WO94/25925 PCT Pub. Date Nov. 10, 1994A method of and apparatus for the deconvolution of response data obtained from transmission of a maximum length sequence, wherein the samples of incoming data are deconvoluted and stored in a reconstruction buffer as said samples are received. It is possible in this way to employ a reconstruction buffer shorter than that necessary to store the complete deconvoluted waveform.
Patent AU-705807-B2 (AU)
Title: Cardiac tropism radiopharmaceutical products incorporating a nitride complex of a transition metal and having a rapid myocardial clearance
Inventor: BELLANDE EMMANUEL
IPC: A61K51/00
Filed: 1996-07-16
Granted: 1999-06-03
Abstract: PCT No. PCT/FR96/01103 Sec. 371 Date Jan. 16, 1998 Sec. 102(e) Date Jan. 16, 1998 PCT Filed Jul. 16, 1996 PCT Pub. No. WO97/03705 PCT Pub. Date Feb. 6, 1997The present invention relates to cardiac tropism radiopharmaceutical products incorporating a nitride complex os a transition metal and having a rapid myocardial clearance. These complexes are based on the formula:(M 3BOND N)L1L2 (I)in which M is a transition metal such as 99mTc and L1 and L2 comply with the formula: in which at least one of the R and R' represents a branched alkyl group having one or more ether functions, a tetrahydrofurfuryl or ether group, a tetrahydrofurfuryl or dioxaspiro or dialkoxy piperidino groups.
Patent AU-714378-B2 (AU)
Title: Toy aircraft, flyable by remote guidance in a closed area, particularly in a room
Inventor: DEPARIS JEROME
IPC: A63H27/04
Filed: 1996-07-25
Granted: 1999-12-23
Abstract: A toy aircraft for use in a confined space, particularly a room, including a model aircraft (1) with an electric motor (11) driving a propeller (19) and means for controlling the model aircraft in flight, a remote control device (2) comprising an electrical power supply (21) and electrical control means for controlling the flight of the model aircraft, and a flexible cable (3) electrically connecting the remote control device (2) to the model aircraft (1) to supply power to the electric motor (11) from the electrical power supply and to connect said electrical control means to said steering means. The wing loading of the model aircraft (1) trailing the connecting cable (3) is </= 1.5 g/dm<2>, and the flexible cable is attached to the underside of the model aircraft adjacent to the centre of gravity thereof.
Patent AU-641960-B2 (AU)
Title: Pyrimidine derivatives
Inventor: MILLS STUART DENNETT
IPC: C07D413/04
Filed: 1990-12-10
Granted: 1993-10-07
Abstract: This invention concerns compounds of the formula I: <CHEM> wherein R<1> is (1-10C)alkyl, (3-8C)cycloalkyl, (3-8C)cycloalkyl-(1-4C)alkyl, phenyl or phenyl(1-4C)alkyl, the phenyl moiety of the latter two optionally bearing one or more substituents; R<2> is hydrogen, (1-4C)alkyl, amino or (1-4C)alkylamino; R<6> is (1-4C)alkyl, amino or (1-4C)alkylamino; Q is a group of formula II, in which case R<3> and R<4> are independently hydrogen, (1-4C)alkyl, phenyl or benzyl the phenyl moiety of the latter two optionally bearing one or two substituents; R<5> is hydrogen, (1-4C)alkyl or (2-4C)alkenyl; A and B are independently ethylene or trimethylene; Z is a direct bond between A and B, or an oxy, thio, carbonyl, methylene, ethylenedioxymethylene, ethylidene, or isopropylidene link, or Z is a group of the formula =N.M in which M is hydrogen, (1-6C)alkyl, phenyl or benzyl, the phenyl moiety of the latter two optionally bearing one or two substituents; or Q represents a saturated 9- or 10-membered bicyclic amino group, which is unsubstituted or is substituted by one or two substituents; and Y is a physiologically acceptable anion. The invention also includes certain closely related anhydro-base derivatives which, like the compounds of formula I, possess beneficial effects on the cardiovascular system (and in particular beneficial effects modulated via the sino-atrial node). Also included are pharmacuetical compositions containing compounds of formula I (or a related anhydro-base) as active ingredient, and processes for the manufacture of the various novel compounds.
Patent AU-539951-B2 (AU)
Title: Copolyester
Inventor: MCGIRK RICHARD HEATH
IPC: B32B27/28
Filed: 1981-03-04
Granted: 1984-10-25
Abstract: An elastomeric copolyester having a multiplicity of recurring intralinear long chain and short chain ester units connected through ester linkages wherein:(A) about 75-96 weight percent of said short chain ester units are represented by the following formula(a) -O(CH<sub>2</sub>)<sub>4</sub>O-C-R-C- and(B) about 4-25 weight percent of said long chain ester units are selected from units represented by the following formulasandwhereinG is a divalent radical remaining after removal of hydroxyl groups from a poly(alkylene oxide) glycol having a number average molecular weight of about 400-1100 and a carbon-to-oxygen atomic ratio of 3-4,R is a divalent radical remaining after removal of carboxyl groups from dicarboxylic acids which are provided as a mixture comprising:(1) about 50-90 weight percent terephthalic acid,(2) about 5-25 weight percent of at least one hexacarbocyclic dicarboxylic acid in which the carboxyl groups are attached to the hexacarbocyclic nucleus in a 1,2- or 1,3- relationship(3) about 5-25 weight percent of at least one aliphatic dicarboxylic acid containing 6 to 12 carbon atoms and having at least4 carbon atoms between carboxyl groups, andR' is a divalent radical remaining after the removal of carboxyl groups from dimer acid.
Patent AU-723561-B2 (AU)
Title: An integrated circuit card with a bonus counter and a method of counting bonuses
Inventor: METHLOUTI MOUNJI
IPC: G06K19/00
Filed: 1998-04-03
Granted: 2000-08-31
Abstract: The integrated circuit card (1) proposed by the invention is intended to facilitate the calculation of bonus points by having the card reader send the card an identity (I1) during a transaction. This identity allows the card to recognize (12) the type of service supplier or vendor in each case, and to implement a set of rules unique (5, 11) to this supplier or vendor or, in the absence of such rules, to use standard rules set by the issuer of the card. These rules calculate the bonus points specific to the supplier in question. The bonus points are then cumulated in a counter also reserved exclusively for the same supplier.
Patent AU-744445-B2 (AU)
Title: Targeted gene modification by parvoviral vectors
Inventor: RUSSELL DAVID W
IPC: C12N15/09
Filed: 1998-04-20
Granted: 2002-02-21
Abstract: This invention provides methods for obtaining targeted gene modification in vertebrate cells using parvoviral vectors, including adeno-associated virus (AAV). The parvoviral vectors used in the methods of the invention are capable of targeting a specific genetic modification to a preselected target locus in a cellular genome by homologous pairing.
Patent AU-709254-B2 (AU)
Title: Biological waste water treatment at high sludge concentrations
Inventor: HORZ WOLFGANG
IPC: C02F1/24
Filed: 1996-10-04
Granted: 1999-08-26
Abstract: PCT No. PCT/EP96/04326 Sec. 371 Date Jun. 8, 1998 Sec. 102(e) Date Jun. 8, 1998 PCT Filed Oct. 4, 1996 PCT Pub. No. WO97/13726 PCT Pub. Date Apr. 17, 1997The invention relates to a process for the biological treatment of waste water, in which a mixture of activated sludge and waste water is treated with gas in an activation stage and the activated sludge is separated off from the treated waste water by flotation, wherein the concentration of the activated sludge in the activation stage is >/=6 g/l and wherein the flotation is a pressure-relief flotation.
Patent AU-638569-B2 (AU)
Title: Container and blank for constructing same
IPC: B65D5/63
Filed: 1991-04-19
Granted: 1993-07-01
Abstract: A liquid-carrying, thermoplastic-coated paperboard container includes a top end closure 12, a four-sided body portion 14, and a bottom end closure 15. Various end closure panels (54, etc.) are folded so as to abut against one another to become sealed thereagainst. To effect the sealing, a pressure sensitive, food grade adhesive is applied to at least one of each two abutting surfaces and the abutting surfaces are pressed together without the application of heat or high frequency vibration. The adhesive may be applied to the blank 10 during the converting process, or while the blank is being formed into a container on the forming, filling and sealing machine. <IMAGE>
Patent AU-597716-B2 (AU)
Title: Liquid crystal display
Inventor: LEENHOUTS FRANS
IPC: G09F9/30
Filed: 1987-09-07
Granted: 1990-06-07
Abstract: Liquid crystal display cell consisting of a highly twisted nematic liquid crystal with positive dielectric anisotropy arranged between two electrode plates and polarisers. The optical path difference  DELTA n@d is 0.2 to 0.7  mu m and the thickness/pitch ratio d/P is 0.2 to 0.8. The absolute value of the angle of twist  phi  can be between 120 DEG  and 260 DEG for right-handed or left-handed twist, the angle  psi  between the polarisers can be between 0 DEG  and 180 DEG , and the angle  beta  between the direction of the surface orientation and the direction of polarisation on the plate on the side where light is incident can be between 0 DEG  and 360 DEG . 
<IMAGE>
Patent AU-634066-B2 (AU)
Title: Raglan sleeve surgical gown
IPC: A41D13/12
Filed: 1991-06-03
Granted: 1993-02-11
Abstract: The present invention provides surgical gowns and other garments possessing the advantages of raglan sleeve construction in terms of comfort and freedom of movement, with improved manufacturing efficiency. The garment (100) of the present invention provides a raglan sleeve divided into an upper portion (20) and lower portion (30) joined approximately in the area of the bicep. Waste is greatly reduced by creating a shoulder portion from material removed to form the arm openings in the body portion of the garment. The shoulder portion (20) is attached to the body portion of the garment to form a raglan shoulder portion which extends to about the bicep of the wearer. A sheet of material is cut in a trapezoidal pattern to form a plurality of lower sleeve portions, each of which is attached to a shoulder portion. Gowns made in accordance with the present invention exhibit the flow and shoulder lines of a raglan sleeve construction while making efficient use of the fabric from which the gown is constructed. Methods of making garments such as surgical gowns are also disclosed. <IMAGE>
Patent AU-597457-B2 (AU)
Title: Image display
Inventor: RICHARDS NORMAN DENNIS
IPC: H04N1/21
Filed: 1987-12-22
Granted: 1990-05-31
Abstract: Pixel information representing an image for display is coded using data compression. The data compression consists in obtaining the pixel information as a first matrix of high resolution pixel values, subtracting from this first matrix a second matrix composed of lower resolution pixel values, produced by low pass filtering the first matrix, to produce a third matrix of difference values, sub-sampling the second matrix to produce a fourth matrix of less density lower resolution pixel values and coding the third and fourth matrices. Complementary decoding consists in restituting the second matrix by interpolation filtering the decoded fourth matrix, and combining the restituted second matrix with the decoded third matrix. Loss of accuracy in the decoding method is reduced by coding and then decoding the fourth matrix during the coding method before it is interpolated to full pixel density to form the restituted second matrix which is subtracted from the first matrix to produce the third matrix of difference values. In this way, any sub-sampling and interpolation errors in the restituted fourth matrix occur in both the coding method and the decoding method and therefore cancel out. Figure 3 illustrates the coding method including these coding and decoding steps.